???global.info.a_carregar???
Identification

Personal identification

Full name
Melanie Aguiar

Author identifiers

Ciência ID
6D1F-8500-D2D1
Outputs

Publications

Conference poster
  1. Bailey, Katharine; Aref, Sarah; Alapi, Krisztina; Aguiar, Melanie; Dey, Aditi; Burt, Richard; Soowah, Lee; et al. "CD20 Targeting of Oncolytic Measles Virus in the Treatment of Adult Acute Lymphoblastic Leukemia". Paper presented in American Society of Gene and Cell-Therapy (ASGCT) 21st Annual Meeting, 2018.
  2. Bailey, Katharine; Beaton, Brendan; Kirkwood, Amy; Aguiar, Melanie; Alapi, Krisztina; Clifton-Hadley, Laura; Patrick, Pip; et al. "Re-Thinking The Prognostic Relevance of a CD20 Expression Cut-Off of 20% in Acute Lymphoblastic Leukaemia: Initial Results From The UKALL14 Trial". Paper presented in 23rd European Hematology Association Congress, 2018.
Journal article
  1. "Addition of four doses of rituximab to standard induction chemotherapy in adult patients with precursor B-cell acute lymphoblastic leukaemia (UKALL14): a phase 3, multicentre, randomised controlled trial". The Lancet Haematology 9 4 (2022): e262-e275. http://dx.doi.org/10.1016/s2352-3026(22)00038-2.
    10.1016/s2352-3026(22)00038-2
  2. Aguiar, Melanie. "First Analysis of the UKALL14 Phase 3 Randomised Trial to Determine If the Addition of Rituximab to Standard Induction Chemotherapy Improves EFS in Adults with Precursor B-ALL (CRUK/09/006)". Blood (2019): http://dx.doi.org/10.1182/blood-2019-123374.
    10.1182/blood-2019-123374
  3. Aguiar, Melanie. "Activated stromal cells transfer mitochondria to rescue acute lymphoblastic leukemia cells from oxidative stress". Blood (2019): http://dx.doi.org/10.1182/blood.2019001398.
    10.1182/blood.2019001398